The ears of the African elephant: Unexpected high seroprevalence of Plasmodium ovale and Plasmodium malariae in healthy populations in Western Africa

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Doderer Lang, Cécile ^a   Atchade, Pascal S ^b   Meckert, Lydia ^a   Haar, Elodie ^a   Perrotey, Sylvie ^a   Filisetti, Denis ^a   Aboubacar, Ahmed ^a   Pfaff, Alexander W ^a   Brunet, Julie ^a   Chabi, Nicodème W ^b   Akpovi, Casimir D ^b   Anani, Ludovic ^c   Bigot, André ^c   Sanni, Ambaliou ^b   Candolfi, Ermanno ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF ABOMEY CALAVI   (Benin)

^c Agence Nationale Pour la Transfusion Sanguine Ministère de la Santé   (Benin)

Author keywords

Africa; ELISA; Plasmodium; Recombinant protein; Seroprevalence

Indexed keywords

PARASITE ANTIGEN; RECOMBINANT ANTIGEN; RPFAMA1 ANTIGEN; RPFMSP1 ANTIGEN; RPMMSP1 ANTIGEN; RPOMSP1 ANTIGEN; UNCLASSIFIED DRUG; PROTOZOON ANTIBODY;

ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; BENIN; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NATIVE ANTIGEN ELISA; NUCLEOTIDE SEQUENCE; PARASITE SERODIAGNOSIS; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE; PLASMODIUM OVALE MALARIA; RECOMBINANT ELISA; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGY; SEROPREVALENCE; AFRICA; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; MALARIA;

AFRICA, WESTERN; ANTIBODIES, PROTOZOAN; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALARIA; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 84902302300     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-240     Document Type: Article

References (30)

1. WHO, World Malaria Report 2012 Geneva: World Health Organization 2012
2. Malaria. Greenwood BM, Bojang K, Whitty CJ, Targett GA, Lancet 2005 365 1487 1498 10.1016/S0140-6736(05)66420-3 15850634 (Pubitemid 40591695)
3. Malaria vaccine developments. Moorthy VS, Good MF, Hill AV, Lancet 2004 363 150 156 10.1016/S0140-6736(03)15267-1 14726170 (Pubitemid 38068334)
4. Isolation and characterization of the MSP1 genes from Plasmodium malariae and Plasmodium ovale. Birkenmeyer L, Muerhoff AS, Dawson GJ, Desai SM, Am J Trop Med Hyg 2010 82 996 1003 10.4269/ajtmh.2010.09-0022 20519591
5. Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates. Muerhoff AS, Birkenmeyer LG, Coffey R, Dille BJ, Barnwell JW, Collins WE, Sullivan JS, Dawson GJ, Desai SM, Clin Vaccine Immunol 2010 17 1631 1638 10.1128/CVI.00196-10 20702658
6. Immunogenicity and protective efficacy of Escherichia coli expressed Plasmodium falciparum merozoite surface protein-1(42) using human compatible adjuvants. Sachdeva S, Mohmmed A, Dasaradhi PV, Crabb BS, Katyal A, Malhotra P, Chauhan VS, Vaccine 2006 24 2007 2016 10.1016/j.vaccine.2005.11.041 16377036 (Pubitemid 43255141)
7. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria. Courtin D, Oesterholt M, Huismans H, Kusi K, Milet J, Badaut C, Gaye O, Roeffen W, Remarque EJ, Sauerwein R, Garcia A, Luty AJ, PLoS One 2009 4 7590 10.1371/journal.pone.0007590 19859562
8. Rapid diagnostic tests for malaria parasites. Moody A, Clin Microbiol Rev 2002 15 66 78 10.1128/CMR.15.1.66-78.2002 11781267 (Pubitemid 34052582)
9. Is a Plasmodium lactate dehydrogenase (pLDH) enzyme-linked immunosorbent (ELISA)-based assay a valid tool for detecting risky malaria blood donations in Africa? Atchade PS, Doderer-Lang C, Chabi N, Perrotey S, Abdelrahman T, Akpovi CD, Anani L, Bigot A, Sanni A, Candolfi E, Malar J 2013 12 279 10.1186/1475-2875-12-279 23927596
10. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Drakeley C, Cook J, Rollinson D, Hay SI, Adv Parasitol 2009 69 299 352 19622411
11. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM, Proc Natl Acad Sci U S A 2005 102 5108 5113 10.1073/pnas.0408725102 15792998
12. Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Druilhe P, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G, Infect Immun 1986 53 393 397 3525412 (Pubitemid 16073871)
13. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Seed CR, Kitchen A, Davis TM, Transfus Med Rev 2005 19 229 240 10.1016/j.tmrv.2005.02.004 16010653 (Pubitemid 40943574)
14. A new ELISA kit which uses a combination of P. falciparum extract and recombinant P. vivax antigens as an alternative to IFAT for detection of malaria antibodies. Doderer C, Heschung A, Guntz P, Cazenave JP, Hansmann Y, Senegas A, Pfaff AW, Abelrahman T, Candolfi E, Malar J 2007 6 19 10.1186/1475-2875-6-19 17313669 (Pubitemid 46391326)
15. Prospective assessment of a new polymerase chain reaction target (STEVOR) for imported Plasmodium falciparum malaria. Filisetti D, Bombard S, N'Guiri C, Dahan R, Molet B, Abou-Bacar A, Hansmann Y, Christmann D, Candolfi E, Eur J Clin Microbiol Infect Dis 2002 21 679 681 10.1007/s10096-002-0800-7 12373502
16. Genetic polymorphisms influence Plasmodium ovale PCR detection accuracy. Calderaro A, Piccolo G, Perandin F, Gorrini C, Peruzzi S, Zuelli C, Ricci L, Manca N, Dettori G, Chezzi C, Snounou G, J Clin Microbiol 2007 45 1624 1627 10.1128/JCM.02316-06 17360843 (Pubitemid 46762425)
17. Human malaria parasites in continuous culture. Trager W, Jensen JB, Science 1976 193 673 675 10.1126/science.781840 781840
18. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Taylor RR, Egan A, McGuinness D, Jepson A, Adair R, Drakely C, Riley E, Int Immunol 1996 8 905 915 10.1093/intimm/8.6.905 8671680 (Pubitemid 26185928)
19. Malaria infection and disease in an area with pyrethroid-resistant vectors in southern Benin. Damien GB, Djenontin A, Rogier C, Corbel V, Bangana SB, Chandre F, Akogbeto M, Kinde-Gazard D, Massougbodji A, Henry MC, Malar J 2010 9 380 10.1186/1475-2875-9-380 21194470
20. Plasmodium species occurrence, temporal distribution and interaction in a child-aged population in rural Burkina Faso. Gneme A, Guelbeogo WM, Riehle MM, Tiono AB, Diarra A, Kabre GB, Sagnon N, Vernick KD, Malar J 2013 12 67 10.1186/1475-2875-12-67 23421809
21. Plasmodium malariae and Plasmodium ovale "the bashfull" malaria parasites. Mueller I, Zimmerman PA, Reeder JC, Trends Parasitol 2007 23 278 283 10.1016/j.pt.2007.04.009 17459775 (Pubitemid 46783896)
22. The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau. Snounou G, Pinheiro L, Goncalves A, Fonseca L, Dias F, Brown KN, do Rosario VE, Trans R Soc Trop Med Hyg 1993 87 649 653 10.1016/0035-9203(93)90274-T 8296364
23. A longitudinal study of human malaria in the West African Savanna in the absence of control measures: relationships between different Plasmodium species, in particular P. falciparum and P. malariae. Molineaux L, Storey J, Cohen JE, Thomas A, Am J Trop Med Hyg 1980 29 725 737 6969036
24. Seroepidemiological and parasitological evaluation of the heterogeneity of malaria infection in the Gambia. Oduro AR, Conway DJ, Schellenberg D, Satoguina J, Greenwood BM, Bojang KA, Malar J 2013 12 222 10.1186/1475-2875-12- 222 23815826
25. Malarial nephropathy. Eiam-Ong S, Semin Nephrol 2003 23 21 33 10.1053/snep.2003.50002 12563598 (Pubitemid 36164466)
26. Relapse of Plasmodium malariae malaria 20 years after living in an endemic area (in French). Siala E, Khalfaoui M, Bouratbine A, Hamdi S, Hili K, Aoun K, Presse Med 2005 34 371 372 10.1016/S0755-4982(05)83926-0 15859572 (Pubitemid 40392973)
27. Plasmodium falciparum and P. malariae epidemiology in a West African village. Boudin C, Robert V, Verhave JP, Carnevale P, Ambroise-Thomas P, Bull World Health Organ 1991 69 199 205 1677615
28. The blood-stage dynamics of mixed Plasmodium malariae-Plasmodium falciparum infections. Mason DP, McKenzie FE, Bossert WH, J Theor Biol 1999 198 549 566 10.1006/jtbi.1999.0932 10373354 (Pubitemid 29332763)
29. First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, Methogo BG, Doucka Y, Flamen A, Mordmuller B, Issifou S, Kremsner PG, Sacarlal J, Aide P, Lanaspa M, Aponte JJ, Nhamuave A, Quelhas D, Bassat Q, Mandjate S, Macete E, Alonso P, Abdulla S, Salim N, Juma O, Shomari M, Shubis K, Machera F, Hamad AS, Minja R, et al. N Engl J Med 2011 365 1863 1875 22007715
30. The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland O, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S, Vox Sang 2011 98 468 478